Related Experiment Video
Updated: Jul 20, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Surgical aspects of congestive heart failure
Daniel J Goldstein1, Douglas Smego, Robert E Michler
1Heart Transplantation and Mechanical Circulatory Support Programs, Associate Professor, Department of Cardiothoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY 10467, USA.
Insights
Cardiac transplantation is the gold standard for end-stage congestive heart failure. Novel surgical alternatives are being developed due to donor limitations, offering new hope for heart failure patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Congestive heart failure (CHF) management has advanced, but end-stage CHF still relies on cardiac transplantation.
- A significant limitation in cardiac transplantation is the scarcity of suitable organ donors.
- This scarcity drives the need for alternative treatments for advanced heart failure.
Purpose of the Study:
- To explore novel surgical alternatives for end-stage congestive heart failure.
- To discuss the refinement of existing cardiac surgical techniques for heart failure.
- To highlight the potential impact of evolving therapies on heart failure epidemiology.
Main Methods:
- Review of current and emerging surgical strategies for congestive heart failure.
- Discussion of ventricular reconstruction techniques.
- Evaluation of mechanical circulatory support devices as alternatives to transplantation.
Main Results:
- Surgical alternatives include mitral valve repair in failing ventricles.
- Left ventricular reconstruction aims to optimize geometry and pump efficiency.
- Partial or complete ventricular replacement with mechanical devices is an emerging option.
Conclusions:
- Novel surgical approaches are crucial due to donor organ limitations for heart failure treatment.
- Advancements in cardiac surgery and mechanical devices offer promising alternatives.
- The evolution of these therapies is expected to significantly impact the epidemiology of end-stage heart failure.
Abstract:
Despite tremendous advances in the medical management of congestive heart failure the gold standard for the treatment of end stage congestive heart failure remains cardiac transplantation. The acknowledged critical limitation of sufficient suitable organ donors has resulted in the refinement and development of novel surgical alternatives for the treatment of congestive heart failure. These approaches include the extension of current conventional cardiac operations such as mitral valve repair to the failing ventricle, surgically reconstructing the size and shape of the failing left ventricle in order to optimize geometry and render it a more efficient pump, and partial or complete replacement of the ventricle with a mechanical device. The continued evolution of such therapies is likely to one day have a significant epidemiologic impact on patients suffering from end stage heart failure.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

